News and Updates

Explore the latest in pharma: GSK and Merck see ADC trial success, AstraZeneca strikes a $1.5B EGFR deal, and biotechs refine complex patent strategies.

Explore the latest data on XmAb819 for advanced renal cell carcinoma. Discover how this bispecific antibody targets tumor cells in a new Phase 1 study.

Explore the latest clinical updates on darovasertib and IDE849 as IDEAYA Biosciences prepares to present breakthrough oncology data at ESMO 2026.

GSK has discontinued its Phase 3 trial for a chronic cough drug candidate after it failed to meet key efficacy endpoints. Learn the details behind the cut.

Are medical devices exempt from the EU’s new packaging laws? Learn how the PPWR impacts sterile barrier systems and what manufacturers must do to comply.

A novel Alzheimer’s treatment shows promise in repairing damaged DNA and reducing brain inflammation. Learn how this breakthrough may protect neurons.

Trellis Bioscience raises $9M for TRL1068, a promising monoclonal antibody designed to combat antibiotic-resistant bacterial infections.

Zhejiang Huahai recruits a new quality lead from Hengrui to address recent FDA manufacturing citations and improve regulatory compliance standards.

Explore how Kalshi’s new prediction markets are enabling bets on FDA drug approvals and clinical trial results, blending financial risk with medical data.

New prediction markets now allow bets on FDA approvals and clinical trial outcomes. Discover the implications of this shift for medical research and finance.